All Wales Paediatric Steroid Replacement Therapy Card

Similar documents
Clinical Guideline. SPEG MCN Protocols Sub Group SPEG Steering Group

Steroid replacement advice. Information for patients Endocrinology

A Guide to Managing Adrenal Insufficiency and Steroid Replacement in Children and Young People

Adrenal insufficiency. A guide for parents

Adrenal Insufficiency. A guide for school nurses and teachers

Adrenal insufficiency A guide for teenagers and young adults

Managing Addison s Disease

Index No: MMG11/1. Version: 1. Date ratified: 12 th November 2013

What is the best thing to do or say in the Emergency Room to make sure the ER staff knows how to treat me if I am in a crisis??

Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation

Recognising and responding to adrenal emergencies

Glucocorticoid replacement, Steroids, Acute Illness Dr Rupa Ahluwalia, Consultant Physician (NNUH)

Information for health professionals

Hydrocortisone advice for parents

Protocol for Hypoadrenalism / Addison s Disease

Anaesthesia and pain (Daycase Patient) Patient information Leaflet

Paediatric Directorate

Management of acute asthma in children in emergency department. Moderate asthma

Audit of Parenteral Fluid Therapy for Children and Young Persons (aged over 4 weeks & under 16 years)

Patient Information. Acute Kidney Injury (AKI)

Newborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017

DOCUMENT CONTROL PAGE

Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

TYPE 1 DIABETES on a pump

Adrenal Gland Disorders

Adrenal Insufficiency in Children

Staff at the Nottingham Children s Hospital. Guidelines process.

Oral anti-cancer treatment

Clinical Assessment Tool

Continuous Subcutaneous Insulin Infusion (CSII) pump therapy

Running head: THE OPTIMAL TREATMENT FOR ADDISON S DISEASE

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

SHARED CARE PRESCRIBING GUIDELINE Triptorelin (Gonapeptyl Depot 3.75 mg TM, Decapeptyl SR mg TM ) for precocious puberty

In memory of Thomas Addison M.D. Son of Joseph and Sarah Addison. Died June 29th 1860 aged 66 years. For 36 years physician to Guy s Hospital London.

NOTTINGHAM UNIVERSITY HOSPITAL NHS TRUST: Clinical Chemistry Guidelines

Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery

Audit of Adrenal Function Tests. Kate Davies Senior Lecturer in Children s Nursing London South Bank University London, UK

Understanding Acute Kidney Injury. Emotional and. practical support

Title: Improving the patient experience for children with Sickle Cell Disease Author/Responsible Director: Carole Ribbins Director of Nursing

High dose cytarabine (Lymphoma)

Title Protocol for the Management of Asthma

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

ADDISON S DISEASE THE FACTS YOU NEED TO KNOW

A guide for people without a fully working spleen

Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.

Information for all patients taking insulin who are admitted to hospital on day of surgery

Policy for Supporting. Children and Young People with. Diabetes in Education

ISOVALERIC ACIDAEMIA -ACUTE DECOMPENSATION (standard version)

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

Pain relief after day surgery

9/11/2012. Chapter 11. Learning Objectives. Learning Objectives. Endocrine Emergencies. Differentiate type 1 and type 2 diabetes

TYPE 2 DIABETES AND STEROID TABLETS

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Children & Young People Travelling with Type 1 Diabetes

Managing diabetes if you are having a colonoscopy

ESCA: Cinacalcet (Mimpara )

Referral and Ongoing Care for Children with Suspected Diabetes

Tonsillectomy Children s Ward Patient information Leaflet

Managing Exacerbations of COPD (Version 3.0)

Great Ormond Street Hospital for Children NHS Foundation Trust

Package leaflet: Information for the patient. Metopirone 250 mg Capsules Metyrapone

Chronic Obstructive Pulmonary Disease (COPD)

Oxford Kidney Unit A guide to conservative kidney management. Information for Healthcare Professionals

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

Insulin Stress Test. An information guide

Northumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service

Botulinum toxin injections

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

Information about Your Child's MRI Scan

Intravenous anti-cancer treatment

Modified Ponticelli treatment record card

Darland High School Policy

Sorafenib (Nexavar ) For thyroid carcinoma

HYPONATRAEMIA: NUH GUIDELINE FOR INITIAL ASSESSMENT AND MANAGEMENT.

Information Leaflet for parents/carers. Circumcision

A guide to the treatment and management of Childhood Nephrotic Syndrome

An evaluation of the RCPCH Epilepsy Passport

The pillars defining our quality care. We Care!

PHARMACOLOGY AND PHARMACOKINETICS

Medicines Information

Your treatment with XELJANZ

Laparoscopic radical nephrectomy

The Cystic Fibrosis Service at GOSH

The Children s Hospital, Oxford Sedation for clinical procedures Information for parents and carers

Scottish Parliament Region: North East Scotland. Case : Tayside NHS Board. Summary of Investigation

Northumbria Healthcare NHS Foundation Trust. Diabetes & Steroid Therapy. Issued by the Diabetes Service

ENHANCED RECOVERY CARE PROGRAMME FOR ABDOMINAL-BASED BREAST RECONSTRUCTIONS (MS-TRAM/DIEP)

Adrenal Insufficiency

Information leaflet for patients and families. Congenital Adrenal Hyperplasia (CAH)

In Hospital Management of Hypoglycaemia in Adults with Diabetes Mellitus

Essential Shared Care Agreement: Lithium

Nephrotic Syndrome. Author: Paediatric Department Document Number: STHK0862 Version: 5 Review date: 30 June 2020 HELEN WINSTON

Western Locality Shared care information ~ Azathioprine and Mercaptopurine

Cerebral angiography. Information for families. Great Ormond Street Hospital for Children NHS Foundation Trust

Surgical removal of the adrenals

Understanding Methotrexate

THE VALUE OF 24 HOUR PROFILES IN CONGENITAL ADRENAL HYPERPLASIA

Azathioprine treatment for respiratory conditions. Information for patients Respiratory Medicine - Asthma

Transcription:

All Wales Paediatric Steroid Replacement Therapy Card

All Wales Paediatric Steroid Replacement Therapy Card 1.0 BACKGROUND Patients that require long-term steroid replacement therapy for adrenal suppression are at risk of adrenal crises at times of illness. A poster compiled by paediatric consultants at the Abertawe Bro Morgannwg health board documenting these risks can be seen in Appendix 1. There have been adverse incidents where appropriate medical treatment has been delayed or not followed 1. It was brought to the attention of paediatricians in Swansea that paramedics attending incidents were unable to administer the recommended therapy (intramuscular hydrocortisone), despite there being a written health care plan in place. There are several circulating steroid cards in existence. Discussions between members of the Brecon Group resulted in a recommendation that a standardised advice leaflet/card for patients to carry, containing appropriate advice for such circumstances, should be produced for Wales. Discussions with the Welsh Ambulance Service Trust (WAST) have taken place and a card produced in collaboration (see section 2.0). WAST have committed to provide ongoing training of paramedics to recognise the new card and administer intramuscular hydrocortisone at the scene. It is envisaged that all patients at risk of adrenal suppression will carry the new wallet-sized card, which would alert paramedics to their condition, provide emergency contact information and provide advice regarding emergency treatment. This will help to ensure the risks are greatly reduced and ensure patients are treated appropriately with minimisation of adverse events. The patient groups that would carry the card include those with adrenal insufficiency due to: Primary insufficiency (due to abnormalities in adrenal gland) Congenital adrenal hyperplasia Adrenoleukodystrophy Autoimmune adrenalitis or Addison s disease Secondary insufficiency (due to impairment of hypothamic pituitary axis) Hypopituitarism 2.0 PAEDIATRIC STEROID REPLACEMENT THERAPY CARD The following pages show the A4 leaflet version. This should be printed double-sided and folded into thirds. An identical, wallet-sized version is also available. 2

IMPORTANT Instructions for hospital doctor This child has a diagnosis of...... If this child is brought to hospital as an emergency case, the following management is advised: Take blood for U&Es, blood glucose and, if necessary, any other appropriate tests, e.g. blood cultures. Check capillary blood glucose. Give hydrocortisone IV as a bolus (dosage as shown in Table 2) (unnecessary if child has had IM hydrocortisone within the previous 4 hours). Commence IV transfusion of 0.9% saline and 5% dextrose at maintenance rate (extra if dehydrated). Add potassium depending on electrolyte result. If blood glucose < 2.5 mmol/l, give bolus of 2 ml/kg 10% dextrose and monitor blood glucose. If patient is drowsy, hypotensive and peripherally shut down, give 20 ml/kg normal saline. Hydrocortisone must either be given orally or IV if vomiting continues. ON ADMISSION PLEASE INFORM Dr (ext ) If IV hydrocortisone is required, calculate the normal daily dose and triple it. Give this calculated dose as four, equally divided doses, e.g. patient is normally on 10 mg/day, triple dose = 30 mg, given as 7.5 mg qds. Consider giving this increased daily dose as a continuous IV hydrocortisone infusion to severely ill patients (50 mg hydrocortisone in 50 ml normal saline), e.g. if total tripled daily dose = 30 mg hydrocortisone, give infusion of 1.25 mls/hour (30 mg/24 hours). If child is also on DDAVP, fluid balance will need to be monitored carefully and dose alteration considered. Once child is better, the hydrocortisone dose should be reduced back to normal maintenance dose after 2 3 days (for usual dose see Table 1). Some children may also be on fludrocortisone. If vomiting and unable to tolerate this orally, electrolytes will need to be monitored twice daily and appropriate sodium replacement made IV. PAEDIATRIC STEROID REPLACEMENT THERAPY CARD The holder of this card has the condition: ADRENAL INSUFFICIENCY NAME: ADDRESS: DATE OF BIRTH: / / HOSPITAL NUMBER: Hospital Consultant: USEFUL NUMBERS Hospital switchboard: Ward: Paediatric Assessment Unit: Secretary: Specialist Nurse: GP name/address: Tel:

IF YOUR CHILD IS UNWELL In the event of mild to moderate illness, e.g. cold, cough, sore throat, please double the hydrocortisone dose for the duration of the illness (please see Table 1 dose during illness ). If your child takes fludrocortisone this does not need to be doubled. Hydrocortisone must be given by injection if your child; does not get better after you have increased the tablets, or feels drowsy, or is unable to take the tablets orally (e.g. due to continued vomiting). It is vital that you keep a supply of hydrocortisone injection in your fridge. Please check it is not past its expiry date. The emergency dose of hydrocortisone injection is shown in Table 2 and will change as your child gets older. In the event of having to use the injection, you should seek medical attention. If your child continues to be ill, despite increasing the hydrocortisone, or you have needed to use the hydrocortisone injection, telephone your nearest hospital and say that you are bringing your child for assessment or go to A&E. Please take this card with you and show the instructions to the admitting doctor. If you do not have immediate access to transport, ring 999 and present this card to the ambulance crew. TABLE 1: CURRENT ORAL TREATMENT These are the medications your child is currently taking. Ask your doctor to write any changes in doses with the date of the change. Date Medication Tablet size/solution strength Normal dose Dose during illness (e.g. doubled) Morning Morning Lunch Lunch Evening Evening Morning Morning Lunch Lunch Evening Evening TABLE 2: EMERGENCY DOSE OF INTRAMUSCULAR HYDROCORTISONE INJECTION Age of child Dose of intramuscular hydrocortisone injection Under 1 year 25 mg 1 5 years 50 mg Over 5 years 100 mg ANASTHAESIA: IMPORTANT INFORMATION In the event of your child needing an anaesthetic either as an emergency or for a routine procedure, please speak to the admitting doctor and the anaesthetist about hydrocortisone cover for the procedure.

All Wales Paediatric Steroid Replacement Therapy Card REFERENCES 1 Marcovitch H. When are paediatricians negligent? Archives of Disease in Childhood 2011; 96 (2): 117-20. 5

All Wales Paediatric Steroid Replacement Therapy Card APPENDIX 1. POSTER PRESENTED AT BRITISH SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY (BSPED) MEETING All Wales Steroid Card The way forward Dr Kavitha Tharian, Dr Rebekah Pryce, Abertawe Bro Morgannwg University Health Board, Swansea, S.Wales Introduction Children on long term steroid replacement for adrenal insufficiency may need emergency administration of intramuscular (IM) hydrocortisone (HC) when unwell. Potential risk identified Recent incident in Wales A child on long term HC for hypopituitarism became unwell at school. Ambulance crew refused to administer IM HC as underlying diagnosis was not Addison s disease! Fortunately child not significantly unwell. This episode highlighted a potentially serious risk. In the interim In Swansea, patients on long term steroids are registered with Welsh Ambulance Service Trust (WAST) This places alert on ambulance computer system to highlight potential need for Hc to prevent further incidents. The way forward All Wales Steroid Card in conjunction with WAST in development. Once developed paramedics in WAST undergo training to recognise and implement card advice to give IM HC (even if guideline remains unchanged). Potential to be adopted to all UK The issue Majority of paediatric patients needing steroid replacement do not have Addison s disease. (i.e. adrenal insufficiency from other causes) Current ambulance guidelines suggest HC can only be administered for Addison s. This may cause potential life threatening delay in treatment to a large group of patients. All ambulances carry hydrocortisone but unable to administer for adrenal insufficiency. All UK ambulance trusts have same guidelines-potential problem for all UK. Risk Management Issue highlighted to local ambulance service/endocrine groups and BSPED Letters to highlight risk to the ambulance guidelines committee to recommend change in guidelines. Recommend guidelines are clear that any patient on long term steroid replacement may present in adrenal crisis at times of illness and a dose of IM HC should be considered in these circumstances. 6